Literature DB >> 17661004

[Comparison of perioperative methylene blue-stained and permanent Papanicolaou-stained urine cytology to detect patients with high-grade urothelial cancer or the urinary bladder. Part 1].

R Rossi1, T Jaeger, C Börgermann, C Furtkamp, R Moos Stahl, H Rübben, F vom Dorp.   

Abstract

INTRODUCTION: The aim of the study was to investigate whether intraoperative methylene blue-stained and permanent Papanicolaou-stained urine cytologies show comparable accuracy in detection of high-grade urothelial carcinoma. PATIENTS AND METHODS: The study included 130 patients; 50 patients were without malignancy (25 follow-up, 25 with hematuria). In 80 patients transurethral resection due to urothelial carcinoma was performed. Per patient two cytology specimens were prepared: one immediate methylene blue-stained specimen, which was evaluated by the surgeon, and one Papanicolaou-stained permanent cytology slide, which was blinded and evaluated by one urologist.
RESULTS: Cytology results of all patients without malignancy were unsuspicious irrespective of the staining method. Of 80 patients with urothelial carcinoma, 50 showed a low-grade tumor. Sensitivity of tumor detection was 20 and 30% for methylene blue/Papanicolaou-stained slides, respectively. Among 30 patients with high-grade carcinoma, 10 were detected by methylene blue cytology and 30 by Papanicolaou-stained slides, corresponding to a sensitivity of 40 and 100%, respectively.
CONCLUSIONS: The results of standard Papanicolaou-stained urine cytology in the detection of clinically relevant high-grade urothelial carcinoma are excellent. The quality of cytological tumor detection by methylene blue-stained cytology made by different evaluators is insufficient in our opinion.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17661004     DOI: 10.1007/s00120-007-1470-y

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  7 in total

Review 1.  Urine markers for bladder cancer surveillance: a systematic review.

Authors:  Bas W G van Rhijn; Henk G van der Poel; Theo H van der Kwast
Journal:  Eur Urol       Date:  2005-03-23       Impact factor: 20.096

2.  Evaluation of nuclear matrix protein-22 as a clinical diagnostic marker for bladder cancer.

Authors:  Yih-Hsin Chang; Cheng-Hua Wu; Yao-Ling Lee; Po-Hsuan Huang; Yu-Lin Kao; Ming-Yuh Shiau
Journal:  Urology       Date:  2004-10       Impact factor: 2.649

3.  Classification of recurrent esophageal cancer after radical esophagectomy with two- or three-field lymphadenectomy.

Authors:  Hiroyuki Kato; Minoru Fukuchi; Tatsuya Miyazaki; Masanobu Nakajima; Hitoshi Kimura; Ahmad Faried; Makoto Sohda; Yasuyuki Fukai; Norihiro Masuda; Ryokuhei Manda; Hitoshi Ojima; Katsuhiko Tsukada; Hiroyuki Kuwano
Journal:  Anticancer Res       Date:  2005 Sep-Oct       Impact factor: 2.480

Review 4.  Non-invasive urothelial neoplasms: according to the most recent WHO classification.

Authors:  Antonio Lopez-Beltran; Rodolfo Montironi
Journal:  Eur Urol       Date:  2004-08       Impact factor: 20.096

Review 5.  Tumor markers in the diagnosis of primary bladder cancer. A systematic review.

Authors:  Afina S Glas; Daphne Roos; Marije Deutekom; Aeilko H Zwinderman; Patrick M Bossuyt; Karl H Kurth
Journal:  J Urol       Date:  2003-06       Impact factor: 7.450

6.  Grading of transitional cell tumours of the urinary tract by urinary cytology.

Authors:  H Rübben; J Bubenzer; K Bökenkamp; W Lutzeyer; P Rathert
Journal:  Urol Res       Date:  1979-06-22

7.  Correlation of cystoscopy with histology of recurrent papillary tumors of the bladder.

Authors:  Harry W Herr; S Machele Donat; Guido Dalbagni
Journal:  J Urol       Date:  2002-09       Impact factor: 7.450

  7 in total
  1 in total

1.  [Methods and current significance of the evaluation of microscopic haematuria].

Authors:  P Hüppe; F Wawroschek
Journal:  Urologe A       Date:  2011-03       Impact factor: 0.639

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.